4 completed. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Secondary Hyperoxaluria: new trials by email Literature Review of Secondary Hyperoxaluria trials Research Report on Secondary Hyperoxaluria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis Lanthanum Carbonate - Secondary Hyperoxaluria, Nephrolithiasis | Phase 3 | Completed | Universitair Ziekenhuis Brussel | 54 | 2017-08-18 | 2026-08-10 |
| A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria Test Meal - Secondary Hyperoxaluria, Nephrolithiasis | Not applicable | Completed | Allena Pharmaceuticals | 22 | 2016-11-01 | 2021-10-28 |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days ALLN-177, Placebo - Secondary Hyperoxaluria, Nephrolithiasis | Phase 2 | Completed | Allena Pharmaceuticals | 66 | 2015-09-01 | 2017-01-19 |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones ALLN-177 low dose, ALLN-177 mid dose, ALLN-177 high dose - Secondary Hyperoxaluria, Nephrolithiasis | Phase 2 | Completed | Allena Pharmaceuticals | 32 | 2015-07-01 | 2018-01-11 |
Hyperoxaluria (4) · Nephrolithiasis (4) · Kidney Calculi (3) · Kidney Diseases (3) · Urologic Diseases (3) · Urolithiasis (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Calculi (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Urinary Calculi (3) · Urolithiasis (3) · Kidney Diseases (1) · Urologic Diseases (1)
oxalate decarboxylase (2) · reloxaliase (2) · lanthanum carbonate (1)
Allena Pharmaceuticals (3) · Universitair Ziekenhuis Brussel (1)
United States (3) · Belgium (1)
Annamaria Kausz, MD MS (2) · Annamaria Kausz, MD, MS (1) · Christian Tielemans, MD, PhD (1)